Eliyahu Sharon Kalif
CIK: 0001798443
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Jun 11, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct106.6K shares at avg. $34.10$3.6M - May 14, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct153.3K shares at avg. $35.61$5.5M - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct19.9K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct33.5K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
53.2K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct23.3K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct49.8K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct141.5K shares- - Feb 26, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct345.8K shares at avg. $33.64$11.6M - Jan 27, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
141.5K shares- - Jun 12, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct55.8K shares at avg. $17.08$952K - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct21.4K shares- - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
79.7K shares- - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct183.2K shares- - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct23.3K shares- - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct33.5K shares- - Mar 3, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct49.8K shares- - Feb 28, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct55.8K shares at avg. $16.21$903K - Jan 28, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
183.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 106,563 | $34.10 | $3,633,308 | Direct |
| May 14, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 153,251 | $35.61 | $5,457,375 | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 19,916 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 33,512 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 53,175 | - | - | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 23,251 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 49,800 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 141,478 | - | $0 | Direct |
| Feb 26, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 345,810 | $33.64 | $11,634,708 | Direct |
| Jan 27, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 141,478 | - | - | Direct |
| Jun 12, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 55,775 | $17.08 | $952,464 | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 21,390 | - | - | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 79,664 | - | - | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 183,169 | - | - | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 23,251 | - | - | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 33,512 | - | - | Direct |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 49,800 | - | - | Direct |
| Feb 28, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 55,750 | $16.21 | $903,462 | Direct |
| Jan 28, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 183,169 | - | - | Direct |
1-19 of 19 transactions
About Kalif Eliyahu Sharon
Kalif Eliyahu Sharon (SEC CIK 0001798443) files insider reports with the SEC as EVP, Chief Financial Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
Signal8 holds 12 ownership filings by Kalif Eliyahu Sharon, all Form 4s, filed between Jan 30, 2025 and Jun 16, 2026. Those filings report 19 transactions, from Jan 28, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kalif Eliyahu Sharon's filings is in TEL AVIV.
Recent filings by Kalif Eliyahu Sharon
- Jun 11, 2026: Open-market sale of TEVA shares (Form 4, code S).
- May 14, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Mar 5, 2026: Option exercise of TEVA shares (Form 4, code M).
- Mar 4, 2026: Option exercise of TEVA shares (Form 4, code M).
- Mar 4, 2026: Grant or award of TEVA derivative securities (Form 4, code A).
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development